AccuSift provides high‑performance mycophenolic acid competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.MPA is a commonly used immunosuppressant after organ transplantation, and its plasma concentration is directly correlated with immunosuppressive efficacy. When the AUC₀‑₁₂ (area under the concentration‑time curve) is maintained at 30–60 mg·h/L, the risk of acute rejection and toxicity can be effectively balanced, improving transplant success.High MPA doses (AUC₀‑₁₂ > 60 mg·h/L) are prone to cause digestive disturbances, increased infection risk, and other problems. Therapeutic drug monitoring allows timely dose adjustments to reduce adverse events.Performance Characteristics:
Sensitivity: ELISA IC50: 10 ppb
Source: Mouse Monoclonal Antibody
Recommended Pairing: (Coating) / (Labeling)
Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.